CHROMACODE, INC.

Profile

Company Names

CHROMACODE, INC.

Addresses

2292 FARADAY AVENUE, SUITE 110, CARLSBAD, CA 92008

2330 FARADAY AVENUE, SUITE 100, CARLSBAD, CA 92008

2075 CORTE DEL NOGAL, CARLSBAD, CA 92011

Phone Numbers

442-244-4370
442-244-4369

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$94,236,388.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-01-30 
$3,849,998.00 
$4,999,997.00 
$1,149,999.00 
Equity 
4
2022-02-28 
$37,967,513.00 
$42,967,511.00 
$4,999,998.00 
Equity 
3
2019-08-09 
$38,643,880.00 
$41,248,842.00 
$2,604,962.00 
Equity 
2
2019-04-04 
$1,750,000.00 
$3,500,000.00 
$1,750,000.00 
Debt 
1
2017-04-17 
$12,024,997.00 
$12,136,023.00 
$111,026.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICK 
 
BALTHROP 
DIRECTOR
NEXTGXDX, INC.   |  PERSONALIS, INC.   |  KLARIS CORP   |  PATTERN BIOSCIENCE, INC.   |  CHROMACODE, INC.
JAMES 
C. 
BLAIR 
DIRECTOR
ZOGENIX INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  INTEGENX INC   |  APPLIED PROTEOMICS, INC.   |  CLOVIS ONCOLOGY, INC.   |  DOMAIN PARTNERS IX, L.P.   |  ATYR PHARMA INC   |  GENE SCIENCES, INC.   |  AXIAL BIOTHERAPEUTICS, INC.   |  CHROMACODE, INC.   |  AXIAL THERAPEUTICS, INC.
ALEXANDER 
G. 
DICKINSON 
DIRECTOR, EXECUTIVE OFFICER
CHROMACODE, INC.
PAUL 
 
FLOOK 
EXECUTIVE OFFICER, DIRECTOR
CHROMACODE, INC.
CAROL 
 
GALLAGHER 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  ANAPTYSBIO INC   |  ARAGON PHARMACEUTICALS, INC.   |  ATTEROCOR, INC.   |  SANTA MARIA BIOTHERAPEUTICS, INC.   |  PINTA BIOTHERAPEUTICS, INC.   |  NINA BIOTHERAPEUTICS, INC.   |  CLEAVE BIOSCIENCES, INC.   |  MILLENDO THERAPEUTICS, INC.   |  METACRINE, INC.   |  PIONYR IMMUNOTHERAPEUTICS, INC.   |  ANNEXON, INC.   |  QPEX BIOPHARMA, INC.   |  CHROMACODE, INC.   |  ASSABET VALLEY BANCORP   |  TREX HOLDINGS INC.   |  ONCORESPONSE, INC
GREGORY 
J. 
GOSCH 
EXECUTIVE OFFICER, DIRECTOR
CHROMACODE, INC.
JUSTIN 
 
KLEIN 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  ULTHERA INC   |  CV INGENUITY CORP.   |  ADVANCED CARDIAC THERAPEUTICS INC   |  VYTRONUS INC   |  CARTIVA, INC.   |  RELIEVANT MEDSYSTEMS INC   |  INTACT VASCULAR, INC.   |  PERSONAL GENOME DIAGNOSTICS INC.   |  VESPER MEDICAL, INC.   |  CHROMACODE, INC.   |  RELIEVANT MEDSYSTEMS, INC.   |  LUNA HEALTH, INC.   |  VENTARIS SURGICAL, INC.
PETER 
JUSTIN 
KLEIN 
DIRECTOR
VERTIFLEX INC   |  VYTRONUS INC   |  VERTIFLEX, INC.   |  SENSEONICS, INC   |  SENSEONICS HOLDINGS, INC.   |  CHROMACODE, INC.   |  INTACT VASCULAR, INC.   |  CLEERLY, INC.
VIKRAM 
 
LAMBDA 
EXECUTIVE OFFICER
CHROMACODE, INC.
CHRISTOPHER 
 
MACGRIFF 
DIRECTOR
CHROMACODE, INC.
MARK 
 
MCDONOUGH 
EXECUTIVE OFFICER, DIRECTOR
COMBIMATRIX CORP   |  PIERIANDX, INC.   |  LIFEGUIDES, PBC   |  CHROMACODE, INC.   |  VESICA HEALTH, INC.
KEVIN 
 
O-BOYLE 
DIRECTOR
CHROMACODE, INC.   |  CARLSMED, INC.
ADITYA 
 
RAJAGOPAL 
DIRECTOR
CHROMACODE, INC.
LYNNE 
 
ROLLINS 
EXECUTIVE OFFICER
HELIXIS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  SONEXA THERAPEUTICS, INC   |  BIONANO GENOMICS, INC   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  TRETHERA CORP   |  GENE SCIENCES, INC.   |  CHROMACODE, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
AXEL 
 
SCHERER 
DIRECTOR
HELIXIS INC   |  NANOMEDIX INC.   |  WIRELESS DIAGNOSTIC SYSTEMS, INC.   |  CHROMACODE, INC.
PAT 
 
SMERKERS 
DIRECTOR
CHROMACODE, INC.
JENNY 
 
YIP 
DIRECTOR
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.   |  STACK DIAGNOSTICS, INC.   |  CHROMACODE, INC.   |  54GENE, INC.   |  ANTIVA BIOSCIENCES, INC.   |  EVOFEM BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-05
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2025-01-30 
2023-02-27
D/A
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2022-02-28 
2022-03-03
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2022-02-28 
2020-12-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2019-08-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
2019-04-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
2017-04-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#